Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,158.00
Bid: 12,156.00
Ask: 12,160.00
Change: -12.00 (-0.10%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: FTSE 100 Slides On US Jobs Data, Miners Weigh

Fri, 06th Mar 2015 16:51

LONDON (Alliance News) - The FTSE 100 ended lower Friday, and ended down over the week as a whole, as London-listed mining stocks were again hit by lower commodity prices, and as stocks in the US were hit by a by a better-than-expected US jobs report that raised expectations the Federal Reserve could start raising interest rates as soon as June.

The FTSE 100 was lower from the start as mining stocks came under pressure from lower commodity prices. The index has a large number of constituents in the sector. It dropped further once the US jobs data was released.

The blue-chip index closed down 0.7% at 6,911.80, meaning it was down 0.5% for the week as a whole. The FTSE 250 closed down 0.2% at 17,272.21, while the AIM All-Share index outperformed, closing up 0.6% at 718.11.

The US Labor Department said non-farm payroll employment jumped by 295,000 jobs in February, following a downwardly revised increase of 239,000 jobs in January. Economists had expected employment to increase by about 230,000 jobs compared with the addition of 257,000 jobs originally reported for the previous month.

The US unemployment rate fell to 5.5% in February, from 5.7% in January, coming in below economists' estimates for a rate of 5.6% and recording its lowest level since hitting 5.4% in May of 2008.

"I think this is a very good labour market report and will only feed into expectations for a rate hike from the Federal Reserve in June," said Oanda analyst Craig Erlam.

But Erlam thinks the June meeting may just come a little soon, with wage growth not quite taking off yet. "I still believe that the Fed will wait until September to act. They are clearly in no rush to make this decision and with inflation below target, they don’t need to," he said.

The dollar strengthened further against its major counterparts in the wake of the report, trading the pound at USD1.5081 while the euro was at its lowest level since September 2003 at USD1.0876.

The gold price fell due to the dollar's rise, and was quoted at USD1,174.02 when the London equity markets closed, its lowest level since early January.

When the London equity markets closed, Wall Street was lower, with the DJIA down 1.0%, the S&P 500 down 0.8% and the Nasdaq Composite down 0.6%. Tech giant Apple will replace AT&T in the DJIA on March 18.

In Europe, the CAC 40 in Paris closed up 0.1%, and the DAX 30 in Frankfurt ended up 0.4%.

Fourth quarter eurozone GDP met expectations, rising 0.9% quarter-on-quarter. The figure was a slight improvement on the third quarter reading of 0.8%. The year-on-year figure also matched estimates of 0.3% growth, marginally higher than the 0.2% shown in the third quarter.

The median expectations for UK inflation for the coming year was 1.9% in February compared with 2.5% in November, according to a survey from the Bank of England. This was its lowest level in more than 13 years. UK inflation had fallen to a record low 0.3% in January, dragged by falling motor fuel and food prices.

In London, gold miners suffered from the weakness of the precious metal price, with Randgold Resources ending as the worst performer in the FTSE 100, down 5.3%, followed by Fresnillo, down 5.2%.

Anglo American was down 2.5% while Rio Tinto slid 2.3% as iron ore prices fell to a fresh six-year low, according to reports.

Outside of mining, AstraZeneca closed down 1.6%. The pharmaceutical giant guided that it expects its total revenue to decline by a mid-single digit percentage at constant exchange rates in 2015, in line with previous sales revenue guidance it gave at the time of its full-year results, as it announced changes to the way it presents its revenue. AstraZeneca maintained its core earnings per share guidance.

Oil and gas service company Weir Group was the biggest gainer in the blue-chip index, up 4.3% at 1,827 pence, as several media reported speculation that it could attract a bid from a US private equity firm. The Independent said that GE Capital is being linked with making a 2,800.00 pence per share bid, though it attributed this to "starry-eyed punters".

Shares in FTSE 250-listed Thomas Cook Group flew up 25%, after Chinese investment firm Fosun International bought a 5% stake in the UK travel operator and said it plans to increase its stake to 10% by buying shares in the open market over time.

Under the deal, Thomas Cook will issue Fosun with 73.1 million new shares for GBP91.8 million, giving it a 5% stake in the business. Fosun will then buy shares in the open market to take its stake up to about 10% over time. The share issue values Thomas Cook shares at 125.58 pence.

In the corporate calendar Monday, WPP, Clarkson, HgCapital Trust, Hansteen Holdings and Mincon Group will issue full year results, while Gemfields and Abcam will release half year results.

In the economic calendar, German current account and import and export data are due at 0700 GMT. Eurozone sentix investor confidence is at 0930 GMT followed by the Eurogroup meeting in Brussels at 1530 GMT. In the US, Labor market conditions index is at 1400 GMT.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.